discoveringnovelantihcvcompoundswithinhibitoryactivitiestowardhcvns34aprotease

doi:10.1038/aps.2014.55

	discoveringnovelantihcvcompoundswithinhibitoryactivitiestowardhcvns34aprotease
	Yu Ye; Jing Jingfeng; Tong Xiankun; He Peilan; Li Yuanchao; Hu Youhong; Tang Wei; Zuo Jianping
刊名	actapharmacologicasinica
	2014
卷号	35 期号:8 页码:1074
关键词	HEPATITIS-C VIRUS PLUS RIBAVIRIN REPLICATION TELAPREVIR POTENT EPIDEMIOLOGY BOCEPREVIR hepatitis C virus NS3/4A protease secreted embryonic alkaline phosphatase (Seap) 2,4-diaminoquinazoline carboxamide telaprevir
ISSN号	1671-4083
DOI	10.1038/aps.2014.55
英文摘要	Aim: To discover novel hepatitis C virus (HCV) inhibitors and elucidate the mechanism of action of the active compounds.
资助项目	[Ministry of Science and Technology of PRC (National Basic Research Program of China, 973 Program)]
语种	英语
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/284356]
专题	中国科学院上海药物研究所
作者单位	中国科学院上海药物研究所
推荐引用方式 GB/T 7714	Yu Ye,Jing Jingfeng,Tong Xiankun,et al. discoveringnovelantihcvcompoundswithinhibitoryactivitiestowardhcvns34aprotease[J]. actapharmacologicasinica,2014,35(8):1074.
APA	Yu Ye.,Jing Jingfeng.,Tong Xiankun.,He Peilan.,Li Yuanchao.,...&Zuo Jianping.(2014).discoveringnovelantihcvcompoundswithinhibitoryactivitiestowardhcvns34aprotease.actapharmacologicasinica,35(8),1074.
MLA	Yu Ye,et al."discoveringnovelantihcvcompoundswithinhibitoryactivitiestowardhcvns34aprotease".actapharmacologicasinica 35.8(2014):1074.